Clinical Trial Update: Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC)

View source ↗

Summary

An update on the Faslodex international observational non-interventional study in advanced breast cancer, sponsored by AstraZeneca, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED